A Phase 3, Multi-Center, Randomized, Double-Blind, Double-Dummy, Active Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of RPC1063 Administered Orally To Relapsing Multiple Sclerosis Patients
收藏DataCite Commons2025-12-12 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012129/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of the trial is to determine the safety and efficacy of RPC1063 in patients with relapsing multiple sclerosis.
提供机构：
Vivli
创建时间：
2025-12-11
